InvestorsHub Logo
Followers 34
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: noretreat post# 124963

Thursday, 10/08/2015 7:50:55 AM

Thursday, October 08, 2015 7:50:55 AM

Post# of 403599
From watching the videos and listening to the audio of presentations this member of Cellceutix management is very impressive to me.

""Dr. Jorgensen has had an accomplished career at both large pharmaceutical and earlier stage biotechnology companies. He has held senior leadership positions in the Global Research and Development Division at Pfizer, Inc. Most notably, Dr. Jorgensen led the Zmax single-dose azithromycin clinical development program, the dalbavancin (second generation glycolipopeptide) medical development team, and Pfizer's first vaccine development group. Prior to joining PolyMedix, he served as Vice President, Clinical Research at AMAG Pharmaceuticals, where he oversaw ten global clinical trials across multiple medical areas"

Brilacidin would not be his first experience with globe trials. I wonder if he still has positive connections with his previous employers. I imagine you have met him? What did you think of him?

LEGEND OF ABBREVIATIONS
B = Brilacidin, the antibiotic
K = Kevetrin, the oncology drug
P = Prurisol, the psoriasis drug
SAE = Serious Adverse Event
IND = Investigational New Drug


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News